Skip to content

A Trial of Telemonitoring in Adults With Heart Failure

A Randomized Controlled Trial of Telemonitoring in Older Adults With Heart Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01393314
Enrollment
99
Registered
2011-07-13
Start date
2007-11-30
Completion date
2010-03-31
Last updated
2022-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

This is a randomized controlled trial of telemonitoring vs usual care provided by home care agencies for patients with heart failure. The study hypothesis is that Telemonitoring will reduce hospital re-admission rates, urgent care visits, unscheduled physician appointments, Emergency Room visits in patients with heart failure over the 60 day post hospitalization period.

Detailed description

A 60 day stratified, randomized clinical trial of a home-based telemonitoring system (TEP) vs. usual home-care with educational package (EP). Both Groups will receive intensive patient education and primary care physicians will be prompted to adhere to heart failure management guidelines. The study will be conducted on 100 patients receiving home care nursing services post-hospital discharge. Each participant will be randomized in equal amounts to treatment (TEP) or no treatment (EP).

Interventions

DEVICEHoneywell HomMed Telemonitor

telemonitoring post hospitalization

Sponsors

Case Western Reserve University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Heart Failure (primary or secondary) diagnosis regardless of ejection fraction (EF) and New York Heart Association (NYHA) class II- IV at the time of Home Health Care (HHC) admission and HHC services initiated following a hospital stay

Exclusion criteria

* Inability to stand on a scale, weight over 500 pounds, unable to hear and/or see, or no working land line phone in the residence. * Additional

Design outcomes

Primary

MeasureTime frameDescription
The Amount of Time Participants Are Readmitted to the Hospital or Visit the Emergency Department (ED).Participants were followed for the duration of home care services up to 12 monthsMedian time to combined endpoint to see if/when the participants need to be readmitted to the hospital or visit the ED

Secondary

MeasureTime frameDescription
Kansas City Cardiomyopathy QuestionaireParticipants were followed for the duration of home care services up to 12 monthsHealth Status, Change in Overall Summary Score minimum: 0 maximum: 100 higher scores=better outcome

Participant flow

Participants by arm

ArmCount
Honeywell HomMed Telemonitor
TeleCareOhio Monitor (Honeywell HomeMed) system provides in-home medical monitoring for patients with chronic disease such as heart failure; telemonitoring post hospitalization.
54
Usual Care
Usual care which consists of usual home-care with educational package.
45
Total99

Baseline characteristics

CharacteristicUsual CareTotalHoneywell HomMed Telemonitor
Age, Continuous74.7 years
STANDARD_DEVIATION 11.3
74.85 years
STANDARD_DEVIATION 11.7
75 years
STANDARD_DEVIATION 12.1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
12 Participants21 Participants9 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
33 Participants78 Participants45 Participants
Sex: Female, Male
Female
27 Participants67 Participants40 Participants
Sex: Female, Male
Male
18 Participants32 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 540 / 45
serious
Total, serious adverse events
0 / 540 / 45

Outcome results

Primary

The Amount of Time Participants Are Readmitted to the Hospital or Visit the Emergency Department (ED).

Median time to combined endpoint to see if/when the participants need to be readmitted to the hospital or visit the ED

Time frame: Participants were followed for the duration of home care services up to 12 months

ArmMeasureValue (MEDIAN)Dispersion
Honeywell HomMed TelemonitorThe Amount of Time Participants Are Readmitted to the Hospital or Visit the Emergency Department (ED).60 DaysStandard Deviation 3
Usual CareThe Amount of Time Participants Are Readmitted to the Hospital or Visit the Emergency Department (ED).62 DaysStandard Deviation 8.5
Secondary

Kansas City Cardiomyopathy Questionaire

Health Status, Change in Overall Summary Score minimum: 0 maximum: 100 higher scores=better outcome

Time frame: Participants were followed for the duration of home care services up to 12 months

ArmMeasureValue (MEAN)Dispersion
Honeywell HomMed TelemonitorKansas City Cardiomyopathy Questionaire34.3 score on a scaleStandard Deviation 12.9
Usual CareKansas City Cardiomyopathy Questionaire28.3 score on a scaleStandard Deviation 16.85

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026